Novanta Inc (NOVT)
NASDAQ
Quarter End | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 218,37M | 219,13M | 229,46M | 221,5M | 211,57M | 230,92M | 235,86M | 244,41M |
Revenu d'exploitation | 27,2M | 26,31M | 29,72M | 30,31M | 21,68M | 25,61M | 25,72M | 32,56M |
Revenu avant impôt | 18,94M | 19,74M | 25,27M | 22,99M | 15,75M | 16,92M | 17,13M | 24,23M |
Revenu net | 15,26M | 18,27M | 20,88M | 21,22M | 12,51M | 14,68M | 13,76M | 19,19M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 27,22M | 26,15M | 29,53M | 30,12M | 21,55M | 25,49M | 25,66M | 32,51M |
EBITDA | 18,37M | 43,13M | 46,78M | 46,84M | -8,29M | 31,36M | 59,67M | 53,3M |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Revenu total | 384,76M | 521,43M | 614,34M | 626,1M | 590,62M | 706,79M | 860,9M | 881,66M |
Revenu d'exploitation | 32,56M | 57,34M | 71,01M | 55,28M | 55,89M | 64,05M | 103,08M | 110,5M |
Revenu avant impôt | 32,52M | 76,13M | 61,3M | 45,77M | 48,4M | 56,17M | 87,16M | 83,75M |
Revenu net | 22M | 60,05M | 49,11M | 40,77M | 44,52M | 50,33M | 74,05M | 72,88M |
Dividendes privilégiés | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Résultat de base par action | 0.639 | 1.736 | 1.42 | 1.169 | 1.266 | 1.414 | 2.074 | 2.035 |
EBIT | 34,76M | 83,75M | 70,97M | 55,04M | 55,91M | 63,69M | 102,71M | 109,82M |
EBITDA | 53,54M | 88,1M | 108,07M | 93,56M | 94,18M | 107,45M | 156,24M | 130,94M |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales